These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31331491)

  • 1. Circulating microRNA in cardiovascular disease.
    Fung EC; Butt AN; Eastwood J; Swaminathan R; Sodi R
    Adv Clin Chem; 2019; 91():99-122. PubMed ID: 31331491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease.
    Benning L; Robinson S; Follo M; Heger LA; Stallmann D; Duerschmied D; Bode C; Ahrens I; Hortmann M
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30035774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs as biomarkers for acute myocardial infarction.
    Wang C; Jing Q
    Acta Pharmacol Sin; 2018 Jul; 39(7):1110-1119. PubMed ID: 29698386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
    de Gonzalo-Calvo D; Vea A; Bär C; Fiedler J; Couch LS; Brotons C; Llorente-Cortes V; Thum T
    Eur Heart J; 2019 May; 40(20):1643-1650. PubMed ID: 29688487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Value of Circulating MicroRNA-133a in Patients with Acute Myocardial Infarction.
    Yuan L; Liu X; Chen F; Zhang L; Chen X; Huang Q; Wu D; Yang C; Han Z
    Clin Lab; 2016 Jul; 62(7):1233-1241. PubMed ID: 28164636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
    Zhao G
    J Med Genet; 2018 Nov; 55(11):713-720. PubMed ID: 30177556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs to predict heart failure after acute myocardial infarction in women.
    Lalem T; Devaux Y
    Clin Biochem; 2019 Aug; 70():1-7. PubMed ID: 31132347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brief Review on the Biology and Effects of Cellular and Circulating microRNAs on Cardiac Remodeling after Infarction.
    Parikh M; Pierce GN
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction.
    Liu X; Yuan L; Chen F; Zhang L; Chen X; Yang C; Han Z
    Clin Lab; 2017 Jan; 63(1):101-109. PubMed ID: 28164501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.
    Tijsen AJ; Pinto YM; Creemers EE
    Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1085-95. PubMed ID: 22942181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in Cardiac Diseases.
    Colpaert RMW; Calore M
    Cells; 2019 Jul; 8(7):. PubMed ID: 31323768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale rapid detection of circulating microRNAs in plasma for diagnosis and screening of specific diseases.
    Ding H; An Y; Zhao T; Liu B; Wang Y; Zhang L; Wang Y; Zhang Y; Wang M; Dong Y; Hu L; Zhao BC; Li P
    Nanoscale; 2019 Sep; 11(36):16879-16885. PubMed ID: 31482918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as biomarkers for clinical studies.
    Pogribny IP
    Exp Biol Med (Maywood); 2018 Feb; 243(3):283-290. PubMed ID: 28914096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.